EuroBACT-II

Hospital‑acquired BSI in #ICU, @EuroBact2 study 🧫 mainly due to Gram -, widespread carbapenem resistant, DTR pathogens 🧫 resistance associated w longer delays to adequate ABTs 🧫 at day-28 mortality 37%, 16% discharged alive #FOAMcc 🖇️ rdcu.be/c5nEP ⬇️ visual abstract

The Eurobact-2 study is now published in @yourICM - 2600 patients with Hospital‑acquired bloodstream infections. We thank the 699 contributors from 333 ICUs in 52 countries who made this collaborative study a reality. @DallongevilleC4 @AlexisT @ICUREsearch_eu

@JosOscarAceved2 Muchas gracias.

@EuroBact2 Exitos... lo mejor para vos !!!

⚠️Dear all, after 2 years spent by your side, I inform you that I am leaving my post at ICUREsearch tomorrow for new horizons. It was a great pleasure to collaborate with you, and very enriching, on the Eurobact II study. ⚠️🙏🙏🙏

🙏🙏🙏I wish you all the best, both professionally and personally. Thank you again for your trust over the past 2 years. My best wishes. Caroline Dallongeville 🙏🙏🙏 @DallongevilleC4 @AlexisT @EuroBact2

⚠️I would continue to follow this from a distance with great interest. The "eurobact@gmail.com" mailbox will still be active. My ICUREsearch mailbox "caroline.dallongeville@icuresearch.eu" will be redirected to the mailbox of one of my colleagues.⚠️

#LIVES2021 is now over - thank you for contributing to its success - YOUR success! Gearing up for 2022, "we will take every step to support #ICU teams with access to research & education so that ICU patients & families get the best care", says President @DrMCecconi #WeAreICU

Bird's eye overview of the @ESICM #ResearchCommittee activities - I feel privileged for having had the opportunity to lead the committee in the past years 🙏🙏 GuyFrancois and ValerieFarrow for your assistance in so many ways! #LIVES2021

Eurobact II first results will be presented by @AlexisT at @ESICM Icuresearch team who contribute to the study give is support to Dr Tabah for his presentation.

⚠️ Important information: more than 30 centers are being closed, and analyzes can begin. Thank you to the National Coordinators for their help in closing these last centers as soon as possible. ⚠️ @EuroBact2 @AlexisT @DallongevilleC4

💡Home straight: more than twenty centers to close. Thank you all for your involvement despite the 3rd wave of COVID which affects many countries. 👏🙏 @EuroBact2 @AlexisT @DallongevilleC4

In March, we closed 1⃣3⃣0⃣ centers. Only 6⃣1⃣ left to close. Thank you all for your collaboration, and to our reviewer team for their work. 👏👏👏 @EuroBact2 @AlexisT @DallongevilleC4

‼️‼️Important Information : The next generation of queries is scheduled for tomorrow. We hope this will be the last. We are therefore counting on you to complete and correct your data.‼️‼️ @EuroBact2 @AlexisT @DallongevilleC4

We look forward to the results.

🔎🔎Our review team does an amazing job. More than 80 centers to close, and all centers will have been reviewed. Congratulations. 👏 @EuroBact2 @AlexisT @DallongevilleC4

👏👏👏A big thank you to the National Coordinators who help us to complete the study by relaunching the centers which must finish completing their data. Your help is greatly appreciated, and very important to us. 👏👏👏 @EuroBact2 @AlexisT @DallongevilleC4

🙏👍Our review team is making good progress on reviewing your data. Less than 100 centers remain to be closed. Thank you all for your last efforts to finish completing your eCRFs. 👍🙏 @EuroBact2 @AlexisT @DallongevilleC4

⚠️⚠️Dear National Coordinators, we still need your help. We sent you the latest dashboards yesterday, and we thank you for contacting all the centers that are not yet closed so that they can complete their queries. Thank you for this last effort. ⚠️⚠️ @AlexisT @DallongevilleC4

⚠️Next generation of queries tomorrow. Remember to finish completing your eCRFs. ⚠️ @EuroBact2 @AlexisT @DallongevilleC4

👏👏👏More than half of the centers are closed. Thank you all for your cooperation. 👏👏👏